Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.

Homolka, Susanne; Paulowski, Laura; Andres, Sönke; Hillemann, Doris; Jou, Ruwen; Günther, Gunar; Claassens, Mareli; Kuhns, Martin; Niemann, Stefan; Maurer, Florian P (2020). Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding. Emerging infectious diseases, 26(11), pp. 2549-2554. U.S. National Center for Infectious Diseases 10.3201/eid2611.202602

[img] Text
Günther G_Two pandemics.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (930kB)

In many settings, the ongoing coronavirus disease (COVID-19) pandemic coincides with other major public health threats, in particular tuberculosis. Using tuberculosis (TB) molecular diagnostic infrastructure, which has substantially expanded worldwide in recent years, for COVID-19 case-finding might be warranted. We analyze the potential of using TB diagnostic and research infrastructures for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. We focused on quality control by adapting the 12 Quality System Essentials framework to the COVID-19 and TB context. We conclude that diagnostic infrastructures for TB can in principle be leveraged to scale-up SARS-CoV-2 testing, in particular in resource-poor settings. TB research infrastructures also can support sequencing of SARS-CoV-2 to study virus evolution and diversity globally. However, fundamental principles of quality management must be followed for both TB and SARS-CoV-2 testing to ensure valid results and to minimize biosafety hazards, and the continuity of TB diagnostic services must be guaranteed at all times.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Günther, Gunar

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1080-6040

Publisher:

U.S. National Center for Infectious Diseases

Language:

English

Submitter:

Heidi Lobsiger

Date Deposited:

26 Nov 2020 13:32

Last Modified:

05 Dec 2022 15:42

Publisher DOI:

10.3201/eid2611.202602

PubMed ID:

32956612

Uncontrolled Keywords:

COVID-19 PCR SARS-CoV-2 bacteria bacterial infections coronavirus disease laboratory quality control respiratory infections severe acute respiratory syndrome coronavirus 2 tuberculosis and other mycobacteria viruses zoonoses

BORIS DOI:

10.7892/boris.148506

URI:

https://boris.unibe.ch/id/eprint/148506

Actions (login required)

Edit item Edit item
Provide Feedback